3 December 2024
Symbiosis signals strong growth ambitions with two key commercial appointments in the US
We’re delighted to announce the expansion of the Symbiosis Business Development team with the addition of two highly experienced U.S....
10 October 2024
Symbiosis acquires new manufacturing facility in a deal financed with Barclays Corporate Bank PLC
Symbiosis acquires 20,000 sq/ft facility to increase high-tech manufacturing capabilities, financed by £1.2m from Barclays Corporate Bank PLC. The additional...
30 August 2024
Scottish Enterprise celebrates record results for Scottish economy during visit to Symbiosis
Scottish Enterprise celebrates record results for Scottish economy Strongest ever performance on jobs and capital investment Scottish Enterprise delivered a...
21 November 2023
Symbiosis Pharmaceutical Services granted MHRA licence following a £1M Investment
Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and Advanced...
4 July 2022
Symbiosis Announces £1 Million Investment in an Analytical Testing Capability
Symbiosis has today announced a 1 million GBP (1.2 million Euros, 1.3 million USD) investment in its in-house analytical services...
1 June 2022
Symbiosis Launches a New Video Showcasing our World-class GMP Manufacturing Facility
We are pleased to announce the launch of our new video of the GMP manufacturing facility here at Symbiosis in...
30 March 2022
Symbiosis Announces Successful Completion of UK Research and Innovation (UKRI) Project
Symbiosis announces the completion of a £1.3 million collaborative UKRI-funded project as part of the medicines manufacturing challenge. Symbiosis and...
11 January 2022
Symbiosis Announces Expansion of Capabilities with BSL-2 Manufacturing Upgrade
Symbiosis is delighted to announce an expansion of its capabilities to handle novel and emerging treatments, such as viral based...
12 October 2021
Symbiosis Starts Producing Sevuparin for Modus Therapeutics’ Future Clinical Development in Sepsis/Septic Shock
We’re very proud to announce that Symbiosis is working with Modus Therapeutics Holding AB, a company developing innovative treatments for...
15 September 2021
Symbiosis Announces Successful MHRA Audit and Expanded Facility at its Stirling, UK site
Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing Contract Manufacturing Organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals, and biopharmaceuticals, and...
30 December 2020
Vaccine Success!
Amazing news for everyone with the confirmation that AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK...
30 November 2020
The Scottish Life Sciences COVID-19 Strategic Response Plan
Symbiosis CEO Colin MacKay is a proud member of the ILG (Life Sciences Industry Leadership Group) and they have just...